Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Ultrasound in Obstetrics and Gynecology

Volumn 47, Issue 2, 2016, Pages 228-235

  Sharma, A ^a,b   Burnell, M ^a   Gentry Maharaj, A ^a   Campbell, S ^c   Amso, N N ^d   Seif, M W ^e   Fletcher, G ^a   Brunell, C ^f   Turner, G ^g   Rangar, R ^h   Ryan, A ^a   Jacobs, I ^a,i   Menon, U ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c Create Health Clinic   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^g ROYAL DERBY HOSPITAL   (United Kingdom)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

ovarian cancer screening; ovarian visualization; postmenopausal women; quality assurance; transvaginal scan; UKCTOCS

Indexed keywords

AGED; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ECHOGRAPHY; FEMALE; HEALTH CARE QUALITY; HUMAN; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; OVARY; OVARY TUMOR; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; QUALITY ASSURANCE, HEALTH CARE; ULTRASONOGRAPHY; UNITED KINGDOM;

EID: 84957680337     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14929     Document Type: Article

References (17)

1. Gray JA,. Planning for quality in the NHS breast screening programme. Qual Health Care 1992; 1: 119-123.
2. Timmerman D, Schwarzler P, Collins WP, Claerhout F, Coenen M, Amant F, Vergote, I, Bourne TH,. Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience. Ultrasound Obstet Gynecol 1999; 13: 11-16.
3. van Nagell JR Jr, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, Pavlik EJ, Kryscio RJ,. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer 2007; 109: 1887-1896.
4. Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Kitanaka T,. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer 2008; 18: 414-420.
5. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD,. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011; 305: 2295-2303.
6. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I,. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009; 10: 327-340.
7. Menon U, Gentry-Maharaj A, Ryan A, Sharma A, Burnell M, Hallett R, Lewis S, Lopez A, Godfrey K, Oram D, Herod J, Williamson K, Seif M, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso N, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Skates S, Parmar M, Jacobs I,. Recruitment to multicenter trials-lessons from UKCTOCS: descriptive study. BMJ 2008; 337: a2079.
8. DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol 1993; 51: 7-11.
9. Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I,. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500-505.
10. Sharma A, Burnell M, Gentry-Maharaj A, Campbell S, Amso N, Seif MW, Fletcher G, Brunel C, Turner G, Rangar R, Ryan A, Jacobs I, Menon U,; United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Factors affecting visualisation of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol 2013; 42: 472-477.
11. van Nagell JR Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, Kryscio RJ,. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000; 77: 350-356.
12. Timmerman D., The use of mathematical models to evaluate pelvic masses; can they beat an expert operator? Best Pract Res Clin Obstet Gynaecol 2004; 18: 91-104.
13. Valentin L., Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 1999; 14: 273-283.
14. Van Gorp T, Veldman J, Van Calster B, Cadron I, Leunen K, Amant F, Timmerman D, Vergote I,. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses. Eur J Cancer 2012; 48: 1649-1656.
15. Bodelon C, Pfeiffer RM, Buys SS, Black A, Sherman ME,. Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. J Natl Cancer Inst 2014; 13; 106.
16. Ludovisi M, Mavrelos D, Jurkovic D,. Re: factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol 2014; 43: 600.
17. Yazbek J, Raju SK, Ben-Nagi J, Holland TK, Hillaby K, Jurkovic D,. Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial. Lancet Oncol 2008; 9: 124-131.